- Efficacy, safety and tolerability of oral eletriptan in the acute treatment of migraine: results of a phase III, multicentre, placebo-controlled study across three attacksR Stark
Alfred Hospital, Prahran, Australia
Cephalalgia 22:23-32. 2002..01). Adverse events for all treatments were generally mild or moderate and self-limiting. Eletriptan 40 mg and eletriptan 80 mg both appear to be effective and well-tolerated acute migraine treatments...
- Migraine prophylaxisRichard J Stark
Alfred Hospital, Monash University, Melbourne, Vic, Australia
Med J Aust 189:283-8. 2008..New strategies to aid in medication withdrawal are reviewed. The approach to menstrual migraine and migraine with prominent aura may differ from that for typical migraine. Novel approaches are being explored for these problems...
- Management of migraine in Australian general practiceRichard J Stark
Neurology Department, Alfred Hospital, Melbourne, Vic, Australia
Med J Aust 187:142-6. 2007..To determine the proportion of patients who have a diagnosis of migraine in a sample of Australian general practice patients, and to review the prophylactic and acute drug treatments used by these patients...